About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The work of our group is mainly focused on personalized medicine, including chemical-functional stability studies of drugs in individualized preparations to be administered both orally and parenterally, as well as parenteral nutrition; research focused on the evaluation and/or design of population pharmacokinetic/pharmacodynamic (PK/PD) models and the characterization of the pharmacokinetics of certain drugs of therapeutic interest in the general population or in certain population groups; and research focused on pharmacogenetics and pharmacogenomics. Our research is also focused on advanced interventions: drug evaluation studies (effectiveness, safety and economic studies); and mobile health and telepharmacy.
IP: Investigació clínica observacional i experimental: Centrada en farmacogenètica o farmacogenòmica.
IP: Investigació clínica observacional i experimental: Centrada en l'avaluació de models PK/PD y caracterització PK de fàrmacs d'ele
IP: J. Bruno Montoro Ronsano
IP: David Berlana Martín
IP: Alba Pau Parra Collaborators: - Funding agency: Col·legi de Farmacèutics de Barcelona Funding: 9000 Reference: COFB/PROJECTES/PAU/2025 Duration: 26/06/2025 - 26/06/2026
IP: José Raul Herance Camacho Collaborators: Sofia Rodriguez Fernandez, Sergi Velasco Vila, Clara Ramírez Serra, Azahara Maria Palomar Muñoz, Cristina Gamez Cenzano, Jana Vidal Otero, Carolina Aparicio Gomez, Alberto Roque Pérez, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán, Maria Nazarena Pizzi, Emily Betancourt Fernández, Enrique Franky Vargas, Martha Sahylí Ortega Pijeira, Emily Betancourt Fernández Funding agency: Instituto de Salud Carlos III Funding: 252500 Reference: PI24/01356 Duration: 01/01/2025 - 31/12/2027
IP: Adria Curran Fàbregas Collaborators: Anna Sala Cunill, Vicenç Falcó Ferrer, Yolima Cossio Gil, Ignasi Cardona Pascual, Paula Suanzes Diez, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Núria Castany Viñas, Maria Belén Gutiérrez Iglesias, Silvina Andrea Magnani Funding agency: Laboratorio ViiV Healthcare Funding: 55000 Reference: VIIV/BECAS/2023/CURRAN Duration: 15/01/2024 - 14/01/2026
IP: José Raul Herance Camacho Collaborators: Carolina Aparicio Gomez, Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies, Emily Betancourt Fernández, Jana Vidal Otero, Cristina Gamez Cenzano Funding agency: The Innovative Medicines Initiative Funding: 514560 Reference: IMMUNE-IMAGE_IMI22018 Duration: 01/10/2019 - 31/03/2026
PhD student: Susana Clemente Bautista Director/s: Marta Miarons Font , Oscar Segarra Canton University: Universitat Autònoma de Barcelona Year: 2025
PhD student: Maria José Cabañas Poy Director/s: J. Bruno Montoro Ronsano, Félix Castillo Salinas University: Universitat de Barcelona Year: 2022
PhD student: Maria Josep Carreras Soler Director/s: Josep Tabernero Caturla University: Universidad Autònoma de Barcelona Year: 2020
Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.
